BAKER BROS. ADVISORS LP SMMT Holdings History
BAKER BROS. ADVISORS LP's Summit Therapeutics Inc Holding Summary
As of 2025-03-31, BAKER BROS. ADVISORS LP held 24.42 Mil shares of Summit Therapeutics Inc(SMMT), totaling $471.16 Mil. This investment constitutes 5.27% of their stock portfolio, and BAKER BROS. ADVISORS LP now holds 3.29% of the outstanding Summit Therapeutics Inc(SMMT) stock.
The initial trade took place in 2022Q4. And since then BAKER BROS. ADVISORS LP has made 4 purchases of SMMT, at an average price of $5.13, for a total of 30.73 Mil shares. In addition, there have been 2 sales at an average price of $1.98 for 6.30 Mil shares. Based on historical transaction data and SMMT's current price of $27.63, BAKER BROS. ADVISORS LP's estimated gain on his SMMT holdings is $529.77 Mil, reflecting a 336.14% gain to date.
BAKER BROS. ADVISORS LP SMMT ($27.63) Holding Chart
BAKER BROS. ADVISORS LP SMMT ($27.63) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1